NIP
Nicholas Investment Partners Portfolio holdings
AUM
$1.12B
This Quarter Return
+25.16%
1 Year Return
+50.66%
3 Year Return
+286.38%
5 Year Return
+525.06%
10 Year Return
+2,262.45%
AUM
$1.46B
AUM Growth
+$1.46B
(+11%)
Cap. Flow
-$9.7M
Cap. Flow
% of AUM
-0.66%
Top 10 Holdings %
Top 10 Hldgs %
25.13%
Holding
226
New
28
Increased
57
Reduced
41
Closed
25
Top Buys
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$31.6M |
| 2 |
Merck
MRK
|
$28.3M |
| 3 |
Mirum Pharmaceuticals
MIRM
|
$23.7M |
| 4 |
IMGN
Immunogen Inc
IMGN
|
$23.1M |
| 5 |
Xenon Pharmaceuticals
XENE
|
$13.6M |
Top Sells
| 1 |
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
|
$29.3M |
| 2 |
Madrigal Pharmaceuticals
MDGL
|
$28.4M |
| 3 |
United Therapeutics
UTHR
|
$26.8M |
| 4 |
Sarepta Therapeutics
SRPT
|
$25.8M |
| 5 |
Insulet
PODD
|
$23.6M |
Sector Composition
| 1 | Healthcare | 53.92% |
| 2 | Technology | 13.34% |
| 3 | Industrials | 8.74% |
| 4 | Consumer Discretionary | 4.85% |
| 5 | Energy | 4.51% |
